Cristin-resultat-ID: 1953232
Sist endret: 16. februar 2022, 12:08
NVI-rapporteringsår: 2021
Resultat
Vitenskapelig artikkel
2021

Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women

Bidragsytere:
  • Pascale Renée Cyr
  • Kine Pedersen
  • Anita Lakshmi Iyer
  • Kate Bundorf
  • Jeremy Goldhaber-Fiebert
  • Dorte Gyrd-Hansen
  • mfl.

Tidsskrift

Preventive Medicine Reports
ISSN 2211-3355
e-ISSN 2211-3355
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2021
Publisert online: 2021
Trykket: 2021
Open Access

Importkilder

Scopus-ID: 2-s2.0-85108603138

Beskrivelse Beskrivelse

Tittel

Providing more balanced information on the harms and benefits of cervical cancer screening: A randomized survey among US and Norwegian women

Sammendrag

We aimed to identify how additional information about benefits and harms of cervical cancer (CC) screening impacted intention to participate in screening, what type of information on harms women preferred receiving, from whom, and whether it differed between two national healthcare settings. We conducted a survey that randomized screen-eligible women in the United States (n = 1084) and Norway (n = 1060) into four groups according to the timing of introducing additional information. We found that additional information did not significantly impact stated intentions-to-participate in screening or follow-up testing in either country; however, the proportion of Norwegian women stating uncertainty about seeking precancer treatment increased from 7.9% to 14.3% (p = 0.012). Women reported strong system-specific preferences for sources of information: Norwegians (59%) preferred it come from a national public health agency while Americans (59%) preferred it come from a specialist care provider. Regression models revealed having a prior Pap-test was the most important predictor of intentions-to-participate in both countries, while having lower income reduced the probabilities of intentions-to-follow-up and seek precancer treatment among U.S. women. These results suggest that additional information on harms is unlikely to reduce participation in CC screening but could increase decision uncertainty to seek treatment. Providing unbiased information would improve on the ethical principle of respect for autonomy and self-determination. However, the clinical impact of additional information on women's understanding of the trade-offs involved with CC screening should be investigated. Future studies should also consider country-specific socioeconomic barriers to screening if communication re-design initiatives aim to improve CC screening participation.

Bidragsytere

Pascale Renée Cyr

  • Tilknyttet:
    Forfatter
    ved Avd. for samfunnsmedisin og global helse ved Universitetet i Oslo

Kine Pedersen

  • Tilknyttet:
    Forfatter
    ved Helseledelse og helseøkonomi ved Universitetet i Oslo

Anita Lakshmi Iyer

  • Tilknyttet:
    Forfatter
    ved Helseledelse og helseøkonomi ved Universitetet i Oslo

Kate Bundorf

  • Tilknyttet:
    Forfatter
    ved Duke University

Jeremy Goldhaber-Fiebert

  • Tilknyttet:
    Forfatter
    ved Stanford University
1 - 5 av 8 | Neste | Siste »